These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 33787460)

  • 21. The improvement of nonalcoholic steatohepatitis by Poria cocos polysaccharides associated with gut microbiota and NF-κB/CCL3/CCR1 axis.
    Tan YY; Yue SR; Lu AP; Zhang L; Ji G; Liu BC; Wang RR
    Phytomedicine; 2022 Aug; 103():154208. PubMed ID: 35691078
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Folic acid attenuates high-fat diet-induced steatohepatitis
    Xin FZ; Zhao ZH; Zhang RN; Pan Q; Gong ZZ; Sun C; Fan JG
    World J Gastroenterol; 2020 May; 26(18):2203-2220. PubMed ID: 32476787
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alternative pathway of bile acid biosynthesis contributes to ameliorate NASH after induction of NAMPT/NAD
    Yang N; Sun R; Zhang X; Wang J; Wang L; Zhu H; Yuan M; Xu Y; Ge C; He J; Wang M
    Biomed Pharmacother; 2023 Aug; 164():114987. PubMed ID: 37315437
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ezetimibe, an NPC1L1 inhibitor, is a potent Nrf2 activator that protects mice from diet-induced nonalcoholic steatohepatitis.
    Lee DH; Han DH; Nam KT; Park JS; Kim SH; Lee M; Kim G; Min BS; Cha BS; Lee YS; Sung SH; Jeong H; Ji HW; Lee MJ; Lee JS; Lee HY; Chun Y; Kim J; Komatsu M; Lee YH; Bae SH
    Free Radic Biol Med; 2016 Oct; 99():520-532. PubMed ID: 27634173
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Yellow loosestrife (Lysimachia vulgaris var. davurica) ameliorates liver fibrosis in db/db mice with methionine- and choline-deficient diet-induced nonalcoholic steatohepatitis.
    Son YJ; Jung DS; Shin JM; Kim M; Yoo G; Nho CW
    BMC Complement Med Ther; 2021 Jan; 21(1):44. PubMed ID: 33494735
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Attenuating effects of allantoin on oxidative stress in a mouse model of nonalcoholic steatohepatitis: role of SIRT1/Nrf2 pathway.
    Hamidi-Zad Z; Moslehi A; Rastegarpanah M
    Res Pharm Sci; 2021 Dec; 16(6):651-659. PubMed ID: 34760013
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epigallocatechin gallate attenuated non-alcoholic steatohepatitis induced by methionine- and choline-deficient diet.
    Ding Y; Sun X; Chen Y; Deng Y; Qian K
    Eur J Pharmacol; 2015 Aug; 761():405-12. PubMed ID: 25967348
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exogenous Liposomal Ceramide-C6 Ameliorates Lipidomic Profile, Energy Homeostasis, and Anti-Oxidant Systems in NASH.
    Zanieri F; Levi A; Montefusco D; Longato L; De Chiara F; Frenguelli L; Omenetti S; Andreola F; Luong TV; Massey V; Caballeria J; Fondevila C; Shanmugavelandy SS; Fox T; Mazza G; Argemi J; Bataller R; Cowart LA; Kester M; Pinzani M; Rombouts K
    Cells; 2020 May; 9(5):. PubMed ID: 32429478
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gossypetin Prevents the Progression of Nonalcoholic Steatohepatitis by Regulating Oxidative Stress and AMP-Activated Protein Kinase.
    Oh E; Lee J; Cho S; Kim SW; Won K; Shin WS; Gwak SH; Ha J; Jeon SY; Park JH; Song IS; Thoudam T; Lee IK; Kim S; Choi SY; Kim KT
    Mol Pharmacol; 2023 Nov; 104(5):214-229. PubMed ID: 37595967
    [TBL] [Abstract][Full Text] [Related]  

  • 30. miR-29a Modulates GSK3β/SIRT1-Linked Mitochondrial Proteostatic Stress to Ameliorate Mouse Non-Alcoholic Steatohepatitis.
    Yang YL; Wang PW; Wang FS; Lin HY; Huang YH
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32961796
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A trans fatty acid substitute enhanced development of liver proliferative lesions induced in mice by feeding a choline-deficient, methionine-lowered, L-amino acid-defined, high-fat diet.
    Suzuki-Kemuriyama N; Abe A; Uno K; Ogawa S; Watanabe A; Sano R; Yuki M; Miyajima K; Nakae D
    Lipids Health Dis; 2020 Dec; 19(1):251. PubMed ID: 33317575
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gasdermin D plays a key role as a pyroptosis executor of non-alcoholic steatohepatitis in humans and mice.
    Xu B; Jiang M; Chu Y; Wang W; Chen D; Li X; Zhang Z; Zhang D; Fan D; Nie Y; Shao F; Wu K; Liang J
    J Hepatol; 2018 Apr; 68(4):773-782. PubMed ID: 29273476
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Modulation of SIRT1-mediated signaling cascades in the liver contributes to the amelioration of nonalcoholic steatohepatitis in high fat fed middle-aged LDL receptor knockout mice by dihydromyricetin.
    Zeng Y; Hua YQ; Wang W; Zhang H; Xu XL
    Biochem Pharmacol; 2020 May; 175():113927. PubMed ID: 32217100
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nomilin and its analogue obacunone alleviate NASH and hepatic fibrosis in mice via enhancing antioxidant and anti-inflammation capacity.
    Han Y; Luo L; Li H; Zhang L; Yan Y; Fang M; Yu J; Gao X; Liu Y; Huang C; Fan S
    Biofactors; 2023; 49(6):1189-1204. PubMed ID: 37401768
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Protectin D1 inhibits TLR4 signaling pathway to alleviate non-alcoholic steatohepatitis via upregulating IRAK-M.
    Liu H; Li N; Kuang G; Gong X; Wang T; Hu J; Du H; Zhong M; Guo J; Xie Y; Xiang Y; Wu S; Yuan Y; Yin X; Wan J; Li K
    Free Radic Biol Med; 2024 Jan; 210():42-53. PubMed ID: 37984750
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CXCL10 plays a key role as an inflammatory mediator and a non-invasive biomarker of non-alcoholic steatohepatitis.
    Zhang X; Shen J; Man K; Chu ES; Yau TO; Sung JC; Go MY; Deng J; Lu L; Wong VW; Sung JJ; Farrell G; Yu J
    J Hepatol; 2014 Dec; 61(6):1365-75. PubMed ID: 25048951
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential TM4SF5-mediated SIRT1 modulation and metabolic signaling in nonalcoholic steatohepatitis progression.
    Ryu J; Kim E; Kang MK; Song DG; Shin EA; Lee H; Jung JW; Nam SH; Kim JE; Kim HJ; Son T; Kim S; Kim HY; Lee JW
    J Pathol; 2021 Jan; 253(1):55-67. PubMed ID: 32918742
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Melatonin alleviates diet-induced steatohepatitis by targeting multiple cell types in the liver to suppress inflammation and fibrosis.
    Xu L; Li H; Zhang O; Zhang F; Song M; Ma M; Zhao Y; Ding R; Li D; Dong Z; Jin S; Han W; Ding C
    J Mol Endocrinol; 2023 Jan; 70(1):. PubMed ID: 36356262
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular adaptations underlying the beneficial effects of hydroxytyrosol in the pathogenic alterations induced by a high-fat diet in mouse liver: PPAR-α and Nrf2 activation, and NF-κB down-regulation.
    Valenzuela R; Illesca P; Echeverría F; Espinosa A; Rincón-Cervera MÁ; Ortiz M; Hernandez-Rodas MC; Valenzuela A; Videla LA
    Food Funct; 2017 Apr; 8(4):1526-1537. PubMed ID: 28386616
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Activation of the Nrf2-ARE pathway in hepatocytes protects against steatosis in nutritionally induced non-alcoholic steatohepatitis in mice.
    Lee LY; Köhler UA; Zhang L; Roenneburg D; Werner S; Johnson JA; Foley DP
    Toxicol Sci; 2014 Dec; 142(2):361-74. PubMed ID: 25294219
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.